IRIS
FERRARI, GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.237
NA - Nord America 1.172
EU - Europa 972
SA - Sud America 686
AF - Africa 49
OC - Oceania 5
Totale 5.121
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.117
SG - Singapore 854
CN - Cina 716
BR - Brasile 570
SE - Svezia 424
HK - Hong Kong 307
VN - Vietnam 176
IT - Italia 153
RU - Federazione Russa 110
DE - Germania 83
AR - Argentina 48
GB - Regno Unito 40
IN - India 33
FI - Finlandia 32
BD - Bangladesh 29
JP - Giappone 27
PL - Polonia 26
AT - Austria 23
CA - Canada 23
MX - Messico 22
ID - Indonesia 21
EC - Ecuador 20
IE - Irlanda 19
ES - Italia 15
ZA - Sudafrica 15
FR - Francia 13
TR - Turchia 13
NL - Olanda 11
IQ - Iraq 10
CL - Cile 9
PE - Perù 9
TN - Tunisia 9
UA - Ucraina 9
CO - Colombia 8
PY - Paraguay 8
VE - Venezuela 8
MA - Marocco 6
CH - Svizzera 5
KG - Kirghizistan 5
PK - Pakistan 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
KE - Kenya 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
IR - Iran 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
NR - Nauru 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.121
Salva come PNG Salva come JPEG
Città #
Singapore 338
Hong Kong 306
Shanghai 195
Ashburn 185
Dallas 176
Hefei 129
Beijing 127
Lawrence 112
Princeton 112
Ho Chi Minh City 73
Milan 63
New York 50
Moscow 46
Los Angeles 45
São Paulo 39
Boardman 32
Hanoi 27
Helsinki 24
Tokyo 22
Warsaw 20
Dublin 19
Brooklyn 18
Rio de Janeiro 18
Nuremberg 16
Guangzhou 15
Belo Horizonte 14
Munich 14
Vienna 14
Cesano Boscone 13
Pune 13
Haiphong 12
Poplar 12
Ankara 11
Johannesburg 11
Salvador 10
Xi'an 10
Da Nang 9
Orem 9
Assago 8
Chennai 8
Rome 8
Seattle 8
Stockholm 8
Brasília 7
Denver 7
Frankfurt am Main 7
Lima 7
Nova Iguaçu 7
Porto Alegre 7
Quito 7
San Francisco 7
Shenzhen 7
Thái Bình 7
Wuxi 7
Campinas 6
Houston 6
London 6
Manchester 6
Reston 6
Santa Clara 6
Tianjin 6
Toronto 6
Tunis 6
Turku 6
Aracaju 5
Bishkek 5
Boston 5
Caxias do Sul 5
Goiânia 5
Hangzhou 5
Mexico City 5
Montreal 5
Phoenix 5
Santo André 5
Tashkent 5
Thái Nguyên 5
Turin 5
Washington 5
Anápolis 4
Asunción 4
Betim 4
Changsha 4
Curitiba 4
Dhaka 4
Fortaleza 4
Guarulhos 4
Guayaquil 4
Itajaí 4
Manaus 4
Oklahoma City 4
Querétaro 4
The Dalles 4
Aksum 3
Americana 3
Amsterdam 3
Baku 3
Barcelona 3
Berazategui 3
Bergamo 3
Bogotá 3
Totale 2.686
Salva come PNG Salva come JPEG
Nome #
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 88
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 82
A human PBL immunodeficient mouse model for in vivo preclinical studies of human gene therapy. 81
A clinical protocol for transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA deficient SCID 80
Long-term lineage commitment in haematopoietic stem cell gene therapy 76
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 72
Correcting b-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity 67
Bone marrow as an alternative site for islet transplantation 65
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice 64
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease 62
Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation 61
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells 59
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia 59
A Highly conserved SOX6 double binding site mediates SOX6 gene downregulation in erythroid cells 59
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 59
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers 57
Characterization of Papilloma virus polypeptides from bovine cutaneous fibropapillomas 57
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 57
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease 55
Bone marrow-derived stem cells repopulate glomerular and tubular kidney components - Effect of hyperglycemia 53
A non-producer interfering HIV-1 provirus can be transduced through a MLV-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus 53
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 52
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to Plerixafor alone 51
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 51
Bone marrow as an alternative site for islet transplantation 50
Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer 49
Muscle regeneration by bone marrow-derived myogenic progenitors 49
Terapia genica e malattia ereditaria 49
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy 48
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 48
Gene therapy using haematopoietic stem and progenitor cells 48
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 47
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 47
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets 46
Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant 46
Clinical protocol: transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID 45
In vivo and in vitro models for the analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency. 45
Selective engraftment of genetically modified hematopoietic stem cells by a truncated erythropoietin receptor 45
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 45
Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts 43
Protein kinase a-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity 43
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27 43
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 43
The second transferrin receptor regulates red blood cell production in mice 42
Retroviral vector gene-transfer into donor peripheral-blood lymphocytes for in-vitro selection and in-vivo immunomodulation of donor antitumor immunity after allo-BMT 42
Gene-transfer into peripheral-blood lymphocytes for in-vivo immunomodulation of donor antitumor immunity in a patient affected by EBV-induced lymphoma 42
Retroviral heterogeneity in mouse lymphomas 42
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice 42
Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes 42
Failure to correct murine muscular dystrophy 41
Transcription factor binding sites as genetic determinants of retroviral integration in the human genome 41
Transcription Factor Binding Sites Are Genetic Determinant of Retroviral Integration in the Human Genome 41
Gene therapy for beta thalassemia: preclinical studies on human cells 41
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 41
Gene Therapy Approaches to Hemoglobinopathies 41
Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred Oncogene 40
Persistent and Position Independent Transgene Expression in Erythroid Cells Transduced 40
Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells 40
Clonal analysis of stably transduced human epidermal stem cells in culture 40
Stem cell plasticity: time for a reappraisal? 39
Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans 38
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement 38
In vivo and in vitro models for analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency 38
Terapia Genica 38
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 38
Transfer of the ADA gene into human ADA-deficient T Lymphocytes reconstitutes specific immune functions 38
Strain polymorphism and tentative mapping of mouse ornithine decarboxylase 37
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity 37
The GATA1-HS2 Enhancer allows persistent and position-independent expression of ß-globin transgene 37
Deletion of a negatively acting sequence in a chimeric GATA-1 enchancer-LTR greatly increases retroviral-mediated erythroid expression 37
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression into muscle fibers in vivo 37
Preclinical Assessment of a Gene Therapy Approach to beta-Thalassemia 37
Gene transfer into human primary myogenic cells. 37
Hypomorhic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype 37
gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants 37
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells 36
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 36
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity 36
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients 36
TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO IMMUNOMODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLO-BMT 36
Pancreatic islets recruit mesenchymal stem cells by release of chemokines 36
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermiolysis bullosa 36
Transcript imaging of human T helper cell development using oligonucleotide arrays 35
Towards the correction of the genetic defect in corneal keratinocytes from patients with macular corneal dystrophy type II 35
Retroviral vectors for human gene therapy 35
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement 34
Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function 34
Vector design influences retroviral integration in human hematopoietic cells 34
Safety of retroviral gene marking with a truncated NGF receptor 33
When diagnostics meets translational research: detection of hemoglobin fractions in cellular lysates from in vitro erythroid cultures by Capillarys2 Flex Piercing® analyzer (Sebia) 33
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 33
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia 33
Mesenchymal Cells Appearing in Pancreatic Tissue Culture Are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function 32
The influence of vector design on integration site selection by gamma-retroviral and lentiviral vectors 32
Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: Evidence from a murine model 32
Retroviral vectors for human gene therapy 32
Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo 31
Gene therapy for beta-thalassemia: Preclinical studies on human cells. 31
Lentiviral-transduced HSCs lead to long-term correction of ß-thalassemia by in vivo selection of erythroid progenitors 31
Gene therapy and gene editing strategies for hemoglobinopathies 31
Totale 4.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 7 2 0 1 0 0 0
2021/2022112 0 0 0 43 0 2 1 51 4 5 1 5
2022/2023685 253 169 45 5 2 99 25 52 17 9 6 3
2023/2024369 10 20 30 104 15 45 11 5 0 7 19 103
2024/20251.663 218 42 16 62 48 142 295 177 261 171 105 126
2025/20262.373 409 378 351 804 405 26 0 0 0 0 0 0
Totale 5.254